SABLICH KIM received a stock award from EIGER BIOPHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/11/2022ACC: 0001140361-22-009263
Director
Since Apr 2021
+18K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
18K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6K
Price / share
—
Trade value
—
% of position
New position
3/11/2022
0.00→6K
Total
Net shares
+6K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/11/2022 | A · Award | +6K | — | — | New position | 0.00 | 6K |
| Total | +6K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
12K shares
Shares
+12K
Strike price
5.1
Held after
12K
Exercisable
—
3/11/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock12K shares | 3/11/2022 | A · Award | +12K | 5.1 | — | 12K |